Prognostic factors and survival in elderly breast cancer patients: roles of age, stage and inflammatory markers
Doğancan Akpalamut, Halil İbrahim Ellez, Elif Atağ, Oktay Halit Aktepe, Hüseyin Salih Semiz, Aziz Karaoğlu · 2026
Read Prognostic factors and survival in elderly breast cancer patients: roles of age, stage and inflammatory markers by Doğancan Akpalamut, Halil İbrahim Ellez, Elif Atağ, Oktay Halit Aktepe, Hüseyin Salih Semiz, Aziz Karaoğlu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13317406.txt.
Description
Doğancan Akpalamut and five co-authors study what predicts survival in older breast cancer patients in a 2026 paper. Data on outlook and treatment in this age group are still scarce. The team review records of patients aged sixty-five and older treated at one clinic over more than a decade, with a focus on daily function, other illnesses, and inflammation markers.
Patients over seventy-five got surgery and drug therapy less often, despite like tumor traits, and lived for a shorter span on average. Poor daily function, heavy illness burden, late stage, a high inflammation ratio, and one tumor subtype each predicted death on their own. Surgery linked to lower risk, the analysis found.
Catalog record
| CREATOR | Doğancan Akpalamut, Halil İbrahim Ellez, Elif Atağ, Oktay Halit Aktepe, Hüseyin Salih Semiz, Aziz Karaoğlu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |